trial · primary record
Bone Scan
High Grade Osteosarcoma
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 1122 |
| Primary completion | 2030-03-20 |
| Primary endpoint | Occurrence of dose-limiting toxicity (Feasibility) |
| Registry ID | NCT05691478 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:06.394Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05691478
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.